Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferritin heavy chain 1 pseudogene 15 (FTH1P15) is one of many processed pseudogenes derived from the ferritin heavy chain 1 (FTH1) gene. Like other pseudogenes in the ferritin family, FTH1P15 does not encode a functional protein. Although pseudogenes were historically thought to be non-functional, it is now understood that they can participate in gene regulation at the RNA level. Some ferritin pseudogenes have been shown to act as competing endogenous RNAs (ceRNAs), bind microRNAs, or generate small interfering RNAs (siRNAs), thereby affecting the expression of their functional gene relatives and potentially influencing cellular homeostasis or disease processes such as cancer[6]. However, there are no current data specifically identifying FTH1P15 as a direct therapeutic target, biomarker, or disease driver in its own right. It is part of the broader ferritin pseudogene network that modulates iron metabolism through post-transcriptional regulation[6].
None applicable (no direct protein product, no inhibitors or ligands)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferritin heavy chain 1 pseudogene 15 (FTH1P15).